Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
Technical Update No. 462: Abnormal maternal serum markers and adverse pregnancy outcomes
Read the guideline
Abstract
To review the current data on the association between abnormal first- or second-trimester aneuploidy screening serum markers and adverse pregnancy outcomes, as well as provide health care professionals with recommendations for managing patients with such abnormal serum marker results.
Health care providers involved in antenatal care for pregnant individuals, including general practitioners, obstetricians, midwives, and maternal-fetal medicine specialists.
More in obstetrics and gynaecology
- Expert opinion by the Italian Society of Gynecology of the Third Age (SIGiTE) and the Italian Society of Menopause (SIM) on diagnosis and treatment of premature ovarian insufficiencyEuropean Respiratory Society · 2026
- Preexisting diabetes: Expert consensus from the College of French Gynecologists and Obstetricians and from the French Society of DiabetologyCollege of French Gynecologists and Obstetricians and French Society of Diabetology · 2026
